Our experimental system combining the human ASCT1/ASCT2 double knockout, ectopic expression of species-specific ASCT1 or ASCT2, and infection with pseudotyped vectors enabled comprehensive comparison of RDR group receptor usage. The gene discussed is SLC1A5; the disease is infection.